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Background: Friedreich ataxia is caused by a GAATTC triplet-repeat expansion in the first intron of the FXN gene.
Results: Expansion of the repeats is observed in induced pluripotent stem cells (iPSCs) and can be blocked with either shRNAs
to mismatch repair enzymes or small molecules targeting the repeats.
Conclusion:MutS and MutS are involved in repeat expansion.
Significance: iPSCs provide a model system for studying triplet-repeat expansion.
The genetic mutation in Friedreich ataxia (FRDA) is a hyper-
expansion of the triplet-repeat sequence GAATTC within the
first intron of the FXN gene. Although yeast and reporter con-
struct models for GAATTC triplet-repeat expansion have been
reported, studies on FRDA pathogenesis and therapeutic devel-
opment are limited by the availability of an appropriate cell
model in which to study the mechanism of instability of the
GAATTC triplet repeats in the human genome. Herein,
induced pluripotent stem cells (iPSCs) were generated from
FRDA patient fibroblasts after transduction with the four tran-
scription factors Oct4, Sox2, Klf4, and c-Myc. These cells were
differentiated into neurospheres and neuronal precursors in
vitro, providing a valuable cell model for FRDA. During propa-
gation of the iPSCs, GAATTC triplet repeats expanded at a rate
of about two GAATTC triplet repeats/replication. However,
GAATTC triplet repeats were stable in FRDA fibroblasts and
neuronal stem cells. The mismatch repair enzymes MSH2,
MSH3, andMSH6, implicated in repeat instability in other trip-
let-repeat diseases, were highly expressed in pluripotent stem
cells compared with fibroblasts and neuronal stem cells and
occupied FXN intron 1. In addition, shRNA silencing of MSH2
andMSH6 impeded GAATTC triplet-repeat expansion. A spe-
cific pyrrole-imidazole polyamide targeting GAATTC triplet-
repeat DNA partially blocked repeat expansion by displacing
MSH2 from FXN intron 1 in FRDA iPSCs. These studies suggest
that in FRDA, GAATTC triplet-repeat instability occurs in
embryonic cells and involves the highly active mismatch repair
system.
Nearly 30 hereditary diseases in humans are caused by
expansion of a triplet-repeat sequence in genomic DNA (1, 2).
These expanded sequences are unstable and frequently change
in length during intergenerational transmission and within
somatic cells. However, the mechanisms of expanded triplet-
repeat sequence generation remain enigmatic (3).
Friedreich ataxia (FRDA)2 is caused by heterochromatin-
mediated silencing of the FXN gene, encoding the essential
mitochondrial protein frataxin (4). The genetic mutation in
FRDA is aGAATTC triplet-repeat expansion in the first intron
of FXN, with unaffected alleles having 6–34 repeats in contrast
to 66–1700 repeats in patient alleles. Longer repeats are asso-
ciated withmore severe gene repression, lower frataxin protein
levels, and earlier onset and increased disease severity (5, 6).
Since the GAATTC triplet-repeat expansion mutation was
identified (5), several models have been established to explain
the mechanism of repeat expansion. Using Escherichia coli (7)
and yeast (8, 9) models, GAATTC triplet-repeat expansion has
been observed during cell culture. Mammalian cell models
using a plasmid construct with GAATTC triplet repeats have
shown that the repeat expansions are transcription-, replica-
tion-, and position-dependent (10–12). In addition, mouse
models with expanded GAATTC triplet repeats show somatic
instability in different tissues (13–15). These systemsdiffer sub-
stantially from humans and from each other in terms of DNA
replication rate, the cell type in which GAATTC triplet-repeat
expansion occurs, and chromatin structure. Therefore, studies
on FRDA pathogenesis and therapeutic development are still
limited by the availability of an appropriate cell model in which
to study themechanism of GAATTC triplet-repeat generation
in the human genome.
In our previous work (16), we showed that GAATTC triplet
repeats are highly unstable in FRDA induced pluripotent stem
cells (iPSCs). Liu et al. (17) also reported that GAATTC triplet
repeats are unstable during the generation of iPSCs from
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patient fibroblasts. Importantly, asymptomatic heterozygous
carriers show GAATTC triplet-repeat expansion on the path-
ogenic allele, but not the normal allele. The mismatch repair
(MMR) enzymeMSH2, implicated in repeat instability in other
triplet-repeat diseases, is highly expressed in pluripotent stem
cells and occupies FXN intron 1. In addition, shRNA silencing
of MSH2 impedes GAATTC triplet-repeat expansion (16).
Our findings provide the first human cell model to study the
mechanisms of GAATTC triplet-repeat expansion in the con-
text of the endogenous cellular FXN gene in human cells.
Herein, we found that GAATTC triplet-repeat expansion
occurred only in the iPSCs, but not in FRDA fibroblasts or dif-
ferentiated neurospheres. Repeat expansion involved theMMR
complexes MutS and MutS. These studies suggest that the
generation and expansion ofGAATTC triplet repeats in FRDA
most likely occur in embryonic cells and involve the highly
active MMR system.
EXPERIMENTAL PROCEDURES
Cell Culture—Fibroblasts, embryonic stem cells (ESCs)/iP-
SCs, neurospheres, neurons, and HEK293T cells were grown at
37 °C and 5% CO2. Fibroblasts were cultured with 10% FBS in
minimal essential medium, 2 mM glutamine, 1% nonessential
amino acids, 20 mM HEPES, and 1% antibiotic/antimycotic
(Invitrogen). ESCs/iPSCs were grown on -irradiated mouse
embryonic fibroblasts (GlobalStem, Rockville, MD) in DMEM/
nutrientmixture F-12 with 20%KnockOut serum replacement,
1 mM glutamine, 1% nonessential amino acids, 1% antibiotic/
antimycotic, 0.1 mM -mercaptoethanol (Invitrogen), and 20
ng/ml basic FGF (Stemgent, SanDiego, CA) and passagedman-
ually every 7 or 8 days. Neurospheres were grown in Neuro-
basal-A medium with 2% B-27 supplement, 1% ITS-A supple-
ment, 1% N-2 supplement, 2 mM glutamine, 1% antibiotic/
antimycotic, 10 mM HEPES, 20 ng/ml basic FGF, and 20 ng/ml
EGF (R&D Systems). Neuronal cells were grown on laminin in
Neurobasal-A medium with 2% B-27 supplement, 1% ITS-A
supplement, 1%N-2 supplement, 2mM glutamine, 1% antibiot-
ic/antimycotic, and 10 mMHEPES. HEK293T cells were grown
with 10% FBS in DMEM, 2 mM glutamine, 20 mM HEPES, 1%
nonessential amino acids, and 1% antibiotic/antimycotic.
Derivation of iPSCs—Unaffected and FRDA iPSC derivation
followed previous methods with minor deviations (18). These
normal and FRDA iPSCs have been characterized by standard
methods (16).
Derivation of Neurospheres and Neural Differentiation—In
vitro differentiation of FRDA iPSCs to neurospheres and neu-
rons was performed as described previously (19–22). Briefly,
iPSC colonies were passaged onto high-density -irradiated
mouse embryonic fibroblasts (at 60  103 cells/cm2) with
ROCK inhibitor (10 M; Stemgent). Induction was performed
with either noggin (0.5 g/ml; PeproTech Inc., Rocky Hill, NJ)
or dorsomorphin (5 M; P5499, Sigma-Aldrich) and SB431542
(10 M; 040010, Stemgent) in ESC medium. During induction,
FRDA iPSCs were maintained for 2 weeks without passage.
Subsequently, induced colonies were dissected and transferred
to suspension culture as neurospheres in Neurobasal-A
medium with EGF (20 ng/ml) and basic FGF (20 ng/ml). Neu-
rospheres were maintained as a suspension culture and pas-
saged manually every 4–5 days. Neural differentiation was
performed by dissociating neurospheres with Accutase (Invit-
rogen) and replating onto polylysine/laminin-coated plates at
50 103 cells/cm2. Neurons weremaintained in Neurobasal-A
medium without EGF or FGF for 7 or 8 days after replating.
Flow Cytometry and Immunocytochemistry—Neurospheres
and neurons were dissociated with Accutase. Single cells were
fixed using a BD Cytofix/Cytoperm fixation/permeabilization
kit (BD Biosciences) following the manufacturer’s protocol at
4 °C for 20 min. Primary antibodies were incubated for 30 min
at room temperature: anti-nestin (ab5968, Abcam, Cambridge,
MA) at 1:5000 dilution for neurospheres, anti-Tuj1 (MMS-
435P, Covance, Emeryville, CA) at 1:2500 dilution for neuronal
cells, and Alexa Fluor 488 anti-MAP2B (560399, BD Biosci-
ences) at 1:20 dilution for neuronal cells. Secondary antibodies
(Alexa Fluor 488 goat anti-rabbit IgG (H L; A11034, Invitro-
gen) and Alexa Fluor 488 goat anti-mouse IgG (H L; A11001,
Invitrogen)) were incubated at 1:1000 dilution for 30 min at
room temperature. Cells were analyzed with a FACSCalibur
HTS instrument (BD Biosciences).
For immunocytochemistry, neuronal cells were fixed in 4%
paraformaldehyde for 10min and permeabilized with 0.5%Tri-
ton X-100 in PBS for 10 min at room temperature. Anti-MAP2
(AB5622, Millipore) and anti-Tuj1 primary antibodies in 10%
goat serum in 0.5% Triton X-100 in PBS were incubated over-
night at 4 °C, and Alexa Fluor 488 goat anti-rabbit IgG (H L),
Alexa Fluor 488 goat anti-mouse IgG (H L), and Alexa Fluor
594 goat anti-rabbit IgG (HL;A11012, Invitrogen) secondary
antibodies were incubated at 1:1000 dilution for 1 h at room
temperature, followed by nuclear staining with DAPI.
Nucleic Acid Purification—Total RNA was purified with an
RNeasy Plus minikit (Qiagen) according to the manufacturer.
Genomic DNA was purified by isopropyl alcohol precipitation
of cell lysate prepared in total cell lysis buffer (100mMTris-HCl
(pH 8.5), 5 mM EDTA, 0.2% SDS, 0.2 M NaCl, and 200 g/ml
proteinase K (Roche Applied Science)) (23). Generally, cells
were collected and washed once with PBS. Cell pellets were
incubated in 0.2 ml of lysis buffer overnight at room tempera-
ture. To the lysate was added 1.0 l of 20 mg/ml glycogen
(Roche Applied Science) and 0.2 ml of isopropyl alcohol. After
incubation for 2 h, the precipitated genomicDNAwas collected
by centrifugation and washed twice with 0.5 ml of 70% isopro-
pyl alcohol in TE buffer (10 mM Tris-HCl (pH 7.5) and 1 mM
EDTA). The genomic DNA pellet was heated at 55 °C for 10
min and then resuspended in 40 l of TE buffer overnight at
55 °C.
Conventional PCR, Small-pool PCR (SP-PCR) , and Quanti-
tative RT-PCR (qRT-PCR)—For GAATTC triplet-repeat
length conventional PCRs, Phusion polymerase (New England
Biolabs, Ipswich,MA)was used according to themanufacturer.
20 ng of genomic DNA (6600 genomic equivalents) and 0.1
M primers GAA-104F and GAA-629R were used (12) in 20-l
reactions cycled through the following conditions: denatur-
ation at 98 °C for 5 s, annealing at 70 °C for 15 s, and extension
at 72 °C for 90 s for 40 cycles with a 5-min initial denaturation
and a 5-min final extension. Quantitation of PCR band size was
performed using an inverse power function directly correlating
gel migration of a molecular weight ladder to its known sizes
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(ImageJ software) (24). PCR products from the FXN locus con-
tain 499 bp of non-repeat sequences, so GAATTC triplet-re-
peat number estimations were adjusted accordingly.
SP-PCR was performed using a modification of a previously
published protocol (25). Serial dilutions of genomic DNA rang-
ing from 75 to 750 pg (25–250 genomic equivalents) were pre-
pared in microcentrifuge tubes with 2 M primers GAA-104F
and GAA-629R. Other PCR conditions were according to pre-
vious conventional PCR with 35 cycles. PCR products were
resolved by electrophoresis on 0.8% agarose gels. The products
were analyzed by Southern blotting using an end-labeled
(TTC)9 oligonucleotide probe that specifically hybridizes to the
GAA triplet-repeat sequence.
qRT-PCR analysis was done with a qScript One-Step SYBR
Green qRT-PCR kit (Bio-Rad) according to the manufacturer.
Primers for pluripotent markers were as described (18).MSH2,
MSH3, and GAPDH primers were as described (16). Other
primers used for qRT-PCR were as follows:MSH6_RT02F (5-
AGGAGCAGGAAAATGGCAA-3),MSH6_RT07R (5-CAT-
CTGGGCCATTACAGCTA-3),MAP2_F2 (5-TTTGGAGA-
GCATGGGTCAC-3),MAP2_R2 (5-TGAACTATCCTTGC-
AGACACC-3), nestin_F2 (5-AAGACTTCCCTCAGCTTT-
CAG-3), and nestin_R2 (5-AGCAAAGATCCAAGACGCC-
3). Analysis of relative qRT-PCR data was performed via the
Ct method (26). All qRT-PCR signals were normalized to
GAPDH. Reverse transcription was performed at 50 °C for 20
min, followedbyPCRcycling at 95 °C for 30 s, 55 °C for 30 s, and
72 °C for 30 s for 40 cycles.
Western Analysis—Whole cell extracts in 50 mM Tris-HCl
(pH 7.4), 150 mM NaCl, 10% glycerol, 0.5% Triton X-100, and
protease inhibitor (Roche Applied Science) were electrophore-
sed on polyacrylamide gels and transferred onto nitrocellulose
membranes. Primary antibodies were incubated overnight, and
secondary antibodies were incubated at room temperature for
1 h. Signals were detected using an ODYSSEY CLx infrared
imaging system (LI-COR Bioscience, Lincoln, NE). Blocking
was performed in 5% milk in TBS (137 mM NaCl, 2.7 mM KCl,
and 25 mM Tris-HCl (pH 7.4)) at room temperature for 1 h.
Antibody incubationwas performed in 3%BSA inTBS contain-
ing 0.1% Tween 20. Anti-MSH2 (ab52266) and anti-MSH6
(ab50604) antibodies were obtained from Abcam and used at
1:4000 and 1:1000 dilutions, respectively. Anti-MSH3 (sc-
11441) and anti-actin (sc-8432) antibodies were obtained from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA) and used at
1:200 and 1:400 dilutions, respectively. IRDye 680LT-conju-
gated goat anti-mouse IgG (H  L; 926-68020) and IRDye
800CW-conjugated goat anti-rabbit IgG (H  L; 926-32211)
secondary antibodies were obtained from LI-COR Bioscience
and used at a dilution of 1:5000.
Lentiviral shRNA Transduction—Lentiviral shRNA for tar-
geting MSH2 has been described (16). Lentiviral shRNA con-
structs for targeting MSH6 were generated by cloning an
MSH6-targeted oligonucleotide (5-CCGGGCCAGAAGAAT-
ACGAGTTGAACTCGAGTTCAACTCGTATTCTTCTGG-
CTTTTTG-3) into the vector pLKO.1-puro (Sigma-Aldrich)
at AgeI and EcoRI sites downstream of the U6 promoter. A
vector containing a scrambled shRNA (plasmid 1864) was
obtained from Addgene (Cambridge, MA). Lentiviral particles
were then packaged by cotransfecting human HEK293T cells
using FuGENE 6 reagent (Roche Applied Science) with shRNA
constructs along with psPAX2 (plasmid 12260) and pMD2.G
(plasmid 12259) helper plasmids (Addgene) in HEK293T
medium. Transfected cells were grown at 37 °C for a total of
12 h, and the cell mediumwas changed to human ESCmedium.
Lentivirus-containing supernatants were collected 24 and 48 h
later. Lentivirus-containing supernatant was filtered through a
0.45-m cellulose acetate mesh to remove any contaminating
cells or cell debris. FRDA iPSCs were subjected to two lentiviral
transductions with lentivirus for 12 h at 37 °C with 5 g/ml
Polybrene. Cells were then expanded and subjected to 6 days of
puromycin selection (0.4 g/ml) on drug-resistant DR4 mouse
embryonic fibroblasts (GlobalStem).
Pyrrole-Imidazole Polyamide Treatment—FRDA iPSCs were
incubated with polyamide FA1 (5M) (27) or HIV-1 (5M) (28,
29) or in the absence of polyamide for 6 weeks, and genomic
DNA was purified after each passage. For chromatin immuno-
precipitation, FRDA iPSCswere incubatedwith polyamide FA1
(5M) or in the absence of polyamide for 72 hbefore iPSCswere
collected. Polyamides were synthesized as described previously
(27, 28) and were verified for purity and identity by analytical
HPLC and MALDI-TOF-MS. Characterization of the DNA-
binding properties of the molecules by quantitative DNase I
footprinting has been described (27, 28). A BODIPY FL-poly-
amide conjugate was also used for nuclear uptake studies (27).
Chromatin Immunoprecipitation—Cells were cross-linked
first with 1.5 mM dithiobis(succinimidyl propionate), followed
by 1% formaldehyde. Subsequent ChIP procedures were as
described (4, 16) with anti-MSH2 antibody (sc-494, Santa Cruz
Biotechnology, Inc.). Analysis by qPCR with primers for the
FXN promoter, the region upstream of the GAATTC triplet
repeats, and the region downstream of the repeats was as
described (4, 16).
RESULTS
Generation of Expanded GAATTC Triplet Repeats in FRDA
iPSCs—It is known that expanded GAATTC triplet repeats in
FRDA-associated alleles are genetically highly unstable and
undergo changes in repeat length in both the germ line and
soma (30). Our previous work has shown that GAATTC triplet
repeats in iPSCs in FXN exhibit repeat instability similar to
patient families, where the repeats expand with discrete
changes in length between generations (16). Liu et al. (17) also
reported that reprogramming of FRDA fibroblasts to iPSCs
results in both expansions and contractions of the GAATTC
triplet repeats within the FXN locus. In these studies, conven-
tional PCR (typically using 20 ng of genomic DNA, which
represents 6600 genomic equivalents) was used to assess
GAATTC triplet-repeat length variability in the FRDA fibro-
blasts and iPSCs. This method cannot detect rarer molecules
comprising10% of the total population.
It has been reported that SP-PCR can detect these rarer
mutant molecules. This method constitutes PCR amplification
of the GAATTC repeat sequence in multiple small pools of
input genomic DNA, containing on the order of 0.5–200
genomic equivalents (31). To differentiate whether the
GAATTC triplet-repeat instability observed in FRDA iPSCs is
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similar to somatic or intergenerational instability, SP-PCR was
used to detect rarer molecules with discrete lengths of
GAATTC triplet repeats from FRDA fibroblasts (line
GM03816 from the NIGMS Coriell Depository, homozygous
for expanded GAATTC triplet alleles) and iPSC line 23-3 (pas-
sage 22, derived from GM03816 cells) (16). Conventional PCR
(20 ng,6600 genomic equivalentmolecules/reaction) showed
that fibroblasts and iPSCs carried a distinguished spectrum of
expanded alleles (Fig. 1A). The expanded GAATTC triplet
alleles, seen as double bands by conventional PCR, were thus
resolved into similar bands from the respective constitutional
GAATTC allele sizes (Fig. 1B) in SP-PCR with 75 genomic
equivalent molecules/reaction. Lower DNA template concen-
trations (25 genomic equivalentmolecules/reaction) frequently
showed single-allele discrimination, in which only one of two
homologous expanded alleles was amplified (Fig. 1C). We
believe that these bands reflect the allele length in individual
FRDA genes (haploid genomes). The repeat instability we
observed in FRDA iPSCs resembles the intergenerational
repeat expansions seen in patient families rather than the
repeat instability seen in the somatic cells that are affected in
the disease (6). In this latter case, heterogeneous expansions
and contractions of the repeats are observed, rather than the
discrete changes in repeat length observed on maternal trans-
mission of pathogenic alleles. Our findings are therefore more
similar to this intergenerational repeat instability; however, this
conclusion must be tempered by the fact that derivation of
iPSCs from fibroblasts does not involvemeiosis, as does passage
through the maternal germ line.
GAATTC Triplet-repeat Expansion Rate in FRDA iPSCs—
Upon propagation of the FRDA iPSCs, we found that the
GAATTC triplet repeats continued to expand (Fig. 2A). This
makes FRDA iPSCs an ideal system in which to study the accu-
mulation rate of the GAATTC triplet repeats. We found that
both alleles expanded on passage in culture (from passages 6 to
19). PCR band sizes were quantified by an inverse power func-
tion directly correlating gel migration of a molecular weight
ladder to its component lengths. PCR products from the FXN
locus contain 499 bp of non-repeat sequences, so GAATTC
triplet-repeat numbers were estimated accordingly (Fig. 2B).
FIGURE1.Conventional PCRandSP-PCRofGAATTC triplet repeats fromFRDA fibroblasts and iPSCs.A, conventional PCR amplification (6600genomic
equivalent molecules/reaction) showing the GAATTC triplet repeats from FRDA fibroblasts and iPSCs (passage 22). neg, negative. B and C, SP-PCR analysis of
theGAATTC triplet repeats fromFRDA fibroblasts and iPSCs (passage22) using75 and25genomic equivalent (g.e.)molecules/reaction inB andC, respectively.
3816-fibro and 3816-iPSCs (passage 22) are controls for SP-PCR using 250 genomic equivalent molecules/reaction. The dashed lines are set between the PCR
bands from fibroblasts and iPSCs.
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Because FRDA is a recessive disease, both alleles are affected,
and both alleles expand during iPSC propagation. The rate of
GAATTC triplet-repeat expansion in the longer expanded
allele was greater than in the shorter expanded allele (Fig. 2C).
At each iPSC passage, the longer expanded allele accumulated
13.3 GAATTC triplet repeats, whereas the shorter expanded
allele accumulated 9.6 GAATTC triplet repeats.
Potential links between GAATTC triplet-repeat expansion
and DNA replication have been studied in a mammalian cell
model using a plasmid with GAATTC triplet repeats. In this
plasmid model, GAATTC triplet-repeat expansions have been
found to be replication-dependent (10). In the iPSCs, the accu-
mulation of repeats in each replication could be estimated.
Generally, iPSCs were passaged about every 7 days. It has been
reported that iPSC doubling time is 29 h (32). Therefore, it
can be calculated that GAATTC triplet repeats accumulated at
a rate of 2.3 (longer expanded allele) and 1.7 (shorter
expanded allele) repeats/replication cycle.
GAATTC Triplet-repeat Expansion Occurs in FRDA iPSCs,
but Not in Differentiated Cells—iPSCs are a type of pluripotent
stem cell artificially derived from a non-pluripotent patient
fibroblast cell by inducing the “forced” expression of Oct4,
Sox2, Klf4, and c-Myc. The generated iPSCs are remarkably
similar to naturally isolated pluripotent stem cells (16). We
were curious to determine whether GAATTC triplet-repeat
expansion also occurs in FRDA fibroblasts and neurospheres
(neural stem cells), which can be differentiated from FRDA
iPSCs.
In vitro differentiation of FRDA iPSCs to neurospheres was
performed as described previously (19–22). Neurospheres
showed higher expression of the genesMAP2 and nestin com-
pared with the original fibroblasts and iPSCs (Fig. 3A). Flow
cytometry showed that neurosphere populations were 90%
positive for themarker protein nestin (supplemental Fig. S1). In
addition, these neurospheres could be further differentiated to
neuronal precursor cells (17). The FRDA neuronal precursor
cells expressed neural marker proteins Tuj1 and MAP2, with a
cell population of 93% (Tuj1) and 84% (MAP2), respectively
(supplemental Fig. S1, C–E, and Fig. S2).
FRDA fibroblasts (GM03816 cells) were cultured and pas-
saged everyweek and collected every 3weeks for genomicDNA
(passages 11–23). GAATTC triplet repeats were stable in
FRDA fibroblasts during passage for 12 weeks (Fig. 3B).
GAATTC triplet repeats began to expand in FRDA iPSCs (Fig.
3C) and stop expansion once differentiated into neurospheres,
showing stability at weeks 0, 2, and 4 post-neurosphere
formation (Fig. 3C). Interestingly, GAATTC triplet repeats
continued expanding during the 2 weeks of noggin induction
(passages 9–11*). Moreover, we also observed GAATTC trip-
let-repeat expansion between passage 11* and week 0 prior to
complete neurosphere formation (2 weeks). One possibility is
that intermediate cells may also express some of the pluripo-
tency genes, which maintain GAATTC triplet-repeat expan-
sion. GAATTC triplet repeats were also stable in neurospheres
during a 10-week observation period (Fig. 3D).
Recently, several studies have reported triplet-repeat expan-
sion and contraction during iPSC derivation (17, 33). To con-
firm whether GAATTC triplet-repeat expansion occurred
during the reprogramming, FRDA iPSCs were collected after
reprogramming (first collection from the reprogramming
dishes, passage 0). Two independent clones both showed a
clear expansion at passage 0 and at later passages (Fig. 3E).
One explanation for contractions observed in other studies
(17) is that these iPSC clones came from different fibroblasts,
FIGURE 2. GAATTC triplet-repeat expansion over time. A, gel analysis (from left to right) of PCR products from DNA obtained from FRDA fibroblasts
(GM03816) and FRDA iPSCs (clone 8) at different passages (P). B, analysis of the GAATTC triplet-repeat length using ImageJ software. Repeat numbers are
shown for each allele. C, GAATTC triplet-repeat expansion rate (over passage).
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each with different GAATTC triplet-repeat lengths.
Another explanation is that expansion was not due to the cell
reprogramming but was a consequence of iPSC formation
after reprogramming.
GAATTC triplet repeats accumulate during propagation of
the FRDA iPSCs in a manner analogous to the expansion
observed in FRDA patient families (intergenerational repeat
instability). Importantly, asymptomatic heterozygous carriers
show GAATTC triplet-repeat expansion on the pathogenic
allele, but not the normal allele (16). These observations open a
new avenue for the investigation of the molecular mechanisms
that underlie GAATTC triplet-repeat expansion.
MMR Proteins Are Highly Expressed in iPSCs—It has been
reported that the MMR system is involved in triplet-repeat
instability. In DM1 (myotonic dystrophy 1) transgenic mice,
MSH3 is a limiting factor in the formation of intergenerational
CTGCAG triplet-repeat expansions, whereas MSH6 is not
(34). Our previous work also showed that the MMR enzyme
MSH2 is highly expressed in pluripotent cells and occupies
FXN intron 1, and shRNA silencing of MSH2 impedes
GAATTC triplet-repeat expansion in the FRDA iPSCs (16).
In eukaryotes, MutS homologs MSH2, MSH3, and MSH6
have been identified and participate in MMR in the form of
heterodimers: MutS, MSH2/MSH6, and MutS, MSH2/
FIGURE 3. GAATTC triplet-repeat expansion occurs in FRDA iPSCs, but not in fibroblasts or neurospheres. A, quantitative RT-PCR analysis of mRNA
markers of pluripotency (Oct4, Nanog, and Tert) and neuronal stem cells (MAP2 and nestin). B, gel analysis of PCR products from genomic DNA obtained from
FRDA fibroblasts (GM03816) at different passages. C, gel analysis of PCR products from genomic DNA obtained from FRDA iPSCs and FRDA neurosphere (NS)
at differentpassages (P) orweeks (W).P11*means that iPSCswere inducedwithnoggin.D, GAATTC triplet repeatswere stable in FRDAneurospheresover time.
Gel analysis (from left to right) of PCR products from DNA obtained from FRDA fibroblasts (GM03816) and FRDA neurospheres at different collection times
(weeks 2, 4, 6, 8, and 10). neg, negative. E, GAATTC triplet-repeat expansion over time. Shown are the results from gel analysis of PCR products from DNA
obtained from FRDA fibroblasts (GM03816) and FRDA iPSCs (clones 16-1 and 16-2) at different passages.
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MSH3 (35, 36). Additionally, results in DM1-derived human
ESCs show significantly higher expression levels ofMMR genes
in undifferentiated cells compared with differentiated stages
(37).
Because the protein levels of MSH2, MSH3, and MSH6 do
not always reflect the level of their respective mRNA tran-
scripts but are dependent upon Mut and Mut complex
stability (38), we monitored the levels of MSH2, MSH3, and
MSH6 by Western blotting using extracts from the FRDA
fibroblasts, iPSCs, and neurospheres. Indeed, expression of
MSH2, MSH3, and MSH6 proteins was up-regulated in
FRDA iPSCs compared with the parent fibroblasts (Fig. 4, A
and B). These increased protein levels are not related to a
FRDA phenotype, as unaffected GM08333 iPSCs showed
similar increases in MSH2, MSH3, and MSH6 protein levels
compared with fibroblasts and similar to the expression in
H1 ESCs (Fig. 4, C and D). Once iPSCs were differentiated
into neurospheres, MSH2, MSH3, and MSH6 protein levels
were reduced (Fig. 4, A and B).
MMR Enzymes MSH2 and MSH6 Are Involved in GAATTC
Triplet-repeat Expansion—It has been reported that MutS
(MSH2/MSH6) preferentially recognizes base-base mis-
matches and small insertion/deletion mispaired nucleotides,
whereas MutS (MSH2/MSH3) preferentially recognizes
larger insertion/deletion mispairs (35). Several studies have
pointed to the involvement of MutS in triplet-repeat instabil-
ity (8, 39), and MutS (MSH2/MSH6) may also be involved in
the formation of CTGCAG triplet expansions duringmaternal
transmission (34). Here, we investigated the role of MutS and
MutS in GAATTC triplet-repeat expansion in the FRDA
iPSCs.
It has been shown that shRNA silencing of MSH2 impedes
GAATTC triplet-repeat expansion in the FRDA iPSCs (16);
however, that study did not determine the effect of MSH2
knockdown on the rate of repeat expansion or the role of the
otherMutS andMutS subunits (MSH3 andMSH6) in repeat
expansion. We therefore performed shRNA-mediated knock-
down of the mRNAs encoding each of these proteins in FRDA
iPSCs andmonitored the effects ofMMRknockdown on repeat
expansion. shRNA knockdown of MSH2 reduced the level of
MSH3 protein, leavingMSH6 protein unaffected (Fig. 5A). Due
to the sensitivity of our PCR assay, where amplification of the
shorter allele is more efficient that that of the longer allele and
where changes in repeat length are easier to quantify, we meas-
FIGURE 4. MMR protein expression in fibroblasts, iPSCs, neurospheres, and H1 human ESCs. A, Western blot results for MSH2, MSH3, and MSH6 in
GM03816 fibroblasts, iPSCs, and neurospheres. B, densitometric analysis ofMSH2,MSH3, andMSH6protein normalized to actin inA. C, Western blot results for
MSH2,MSH3, andMSH6 in unaffected fibroblasts (GM08333), unaffected iPSCs (GM08333), andH1 human ESCs.D, densitometric analysis ofMSH2,MSH3, and
MSH6 protein normalized to actin in C. Actin levels were used as a loading control.
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ured changes in repeat length on the shorter allele. The rate of
GAATTC triplet-repeat expansion in the shorter expanded
allele was analyzed afterMSH2 gene knockdown (Fig. 5A). iPSC
genomic DNA was collected after four, six, and eight passages
of MSH2 knockdown. PCR analysis showed that the shorter
expanded alleles accumulated 11.4 GAATTC triplet repeats at
every passage in scrambled control iPSCs, but only 3.6
GAATTC triplet repeats inMSH2 knockdown iPSCs (Fig. 5A).
These data further implicate the involvement of MSH2 in
GAATTC triplet-repeat instability.
FIGURE 5.GAATTC triplet-repeat expansion involvesMMRenzymesMSH2 andMSH6. A, panel 1, Western blot results forMSH2,MSH3, andMSH6 protein
in FRDA iPSCs with scrambled shRNA andMSH2-targeted shRNA (shMSH2). Panel 2, densitometric analysis of MSH2, MSH3, and MSH6 protein normalized to
actin in panel 1. Panel 3, PCR of GAATTC triplet repeats in fibroblasts, iPSCs before silencing (P20) and at four passages (P24), six passages (P26), and eight
passages (P28) after transductionwith scrambled andMSH2 shRNAs.Panel 4, GAATTC triplet-repeat expansion rate (over passage) in iPSCswith scrambled and
MSH2 shRNAs. Here, the rate of GAATTC triplet-repeat expansion in the shorter expanded allelewas analyzed. B, panel 1, Western blot results forMSH2,MSH3,
andMSH6 protein in FRDA iPSCswith scrambled andMSH6-targeted shRNAs. Panel 2, densitometric analysis ofMSH2,MSH3, andMSH6 protein normalized to
actin in panel 1. Panel 3, PCR of GAATTC triplet-repeat length in fibroblasts before silencing (starting iPSCs; P16) and at four passages (P20), six passages (P22),
and eight passages (P24) after transduction with scrambled and MSH6 shRNAs. Panel 4, GAATTC triplet-repeat expansion rate (over passage) in iPSCs with
scrambled and MSH6 shRNAs. Here, the rate of GAATTC triplet-repeat expansion in the shorter expanded allele was analyzed.
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MSH6 gene knockdown was also achieved (Fig. 5B), whereas
MSH3 gene knockdown was unsuccessful (data not shown).
MSH6 gene knockdownwas analyzed at the protein level for all
three MMR subunits, showing that MSH6 protein knockdown
did not affect the MSH2 or MSH3 protein levels significantly
(Fig. 5B). PCR analysis for repeat lengths showed that theMMR
enzyme MutS (MSH2/MSH6) is involved in GAATTC trip-
let-repeat expansion. The shorter expanded allele accumulated
6.5GAATTC triplet repeats at every passage in scrambled con-
trol iPSCs, but only 3.4GAATTC repeats inMSH6 knockdown
iPSCs (Fig. 5B). The difference between the scrambled control
iPSCs in Fig. 5 (A and B) may come from a passage number
difference between lines during the shRNA gene knockdown.
GAATTC Triplet Repeat-targeted Pyrrole-Imidazole Poly-
amide Impedes Repeat Expansion—Biochemical studies have
documented that expanded GAATTC triplet repeats adopt
unusual non-B DNA structures in vitro, such as triplexes, con-
taining two purine GAA strands along with one pyrimidine
TTC strand, flanking a single-stranded pyrimidine region (40),
as well as intramolecular “sticky” DNA (41). Structural studies
indicate that -alanine-linked polyamides bind the minor
groove of canonical B DNA (42). Given the high affinity of -al-
anine-linked polyamides for purine tracts (43), these molecules
might act as a thermodynamic “sink” and lockGAATTC triplet
repeats into double-stranded B DNA. Such an event would dis-
favor duplex unpairing, which is necessary for formation of
FRDA triplexes and sticky DNA, which may lead to GAATTC
triplet-repeat expansion in FRDA iPSCs. It has been shown that
-alanine-linked pyrrole-imidazole polyamide FA1 (ImPy--
ImPy--Im--Dp, where Py is pyrrole, Im is imidazole,  is
-alanine, and Dp is dimethylaminopropylamine) binds
GAATTC triplet-repeat DNA in its B-type conformation,
shifts the equilibrium from sticky DNA back to B-type DNA,
and relieves transcriptional repression of the FXN gene in
FRDA cells (Fig. 6A) (27).
Quantitative DNase I footprinting experiments showed that
polyamide FA1 binds the 9-bp site 5-AAGAAGAAG-3 (as in
GAATTC triplet-repeat DNA) with an apparent dissociation
constant (Kd) of 0.1 nM (27). Quantitative footprint titration
experiments also revealed that polyamide HIV-1 (ImPy--
ImPy--ImPy--ImPy--Dp, where  is -butyric acid) binds
to sites adjacent to and overlapping the HIV-1 TATA element
(5-(A/T)GC(A/T)GC(A/T)-3) with a Kd of 0.05 nM (28), and
subsequent studies showed that this same molecule targets
CAGCTG triplet-repeat DNA with high affinity (Fig. 6B) (29).
Both molecules have been found to be cell-permeable, and flu-
orescent conjugates localize in the cell nucleus (supplemental
Fig. S3) (27, 44). Thus, polyamideHIV-1was used as a control in
the following experiments.We askedwhether these polyamides
would have an effect on GAATTC triplet-repeat expansion in
FRDA iPSCs. At 5 M, FA1 impeded GAATTC triplet-repeat
expansion in FRDA iPSCs, whereas the control polyamide
HIV-1 did not (Fig. 6, C and D).
We postulate that polyamide FA1 reverses a non-B DNA
conformation, causing displacement of MMR enzymes and
thereby preventing repeat expansion. ChIP assays showed that
FA1 removed the MMR enzymeMSH2 from the region down-
stream of the repeats (Fig. 6E). This result was consistent with
theMSH2 shRNA knockdown that removed theMMR enzyme
MSH2 from the region downstream of the repeats (Fig. 6F).
DISCUSSION
Accumulating data from E. coli, yeast, mammalian cell, and
mouse models reveal that somatic gene mosaicism and triplet-
repeat expansion occur as the result of multiple small changes
in length-dependent, transcription-dependent, and DNA
MMR-dependent processes. The most parsimonious model
that can account for these dynamics involves the DNA MMR
machinery (45).
Generation of expanded GAATTC triplet repeats in FRDA
iPSCs can be explained using a MMR model. In this model,
possibly due to transcription and RNADNA hybrid formation
(46), the GAATTC triplet repeats adopt an unusual non-B
DNA structure. The loop outs are recognized by MutS
(MSH2/MSH3) and MutS (MSH2/MSH6), which initiate a
DNA MMR reaction by recruiting a MutL heterodimer. If the
complementary loop outs are far enough apart, they will be
repaired as independent events, and if repair is directed to
incorporate the loop out on the opposite stand, a net gain of
repeats will result that is equivalent to the size of the original
misalignment. Multiple rounds of misalignment and MMR
could lead to the accumulation of large GAATTC triplet-
length changes.
Whether the mechanism of GAATTC triplet-repeat gener-
ation is really as simple as inappropriate DNAMMR remains to
be elucidated. However, progress achieved in understanding
the important factors mediating repeat instability will be
extended through the use of an impressive array of model sys-
tems now established to test competing models. FRDA iPSCs
would be a valuable model to study repeat instability in the
human genome.
Is there any relationship between triplet-repeat instability
and reprogramming? Recently, several studies have reported
triplet-repeat expansions and contractions during iPSC deriva-
tion (17, 33). There are three ways to explain these repeat
expansions and contractions. First, iPSC clones come from a
fibroblast cell with shorter or longer repeats. Second, repeat
expansion occurs during the reprogramming stage. The repeat
size difference between fibroblasts and iPSCs comes from the
propagation of iPSCs. The very early iPSCs (passage 0) showing
expansion in this study resulted after 3 weeks of propagation, in
which transduced fibroblasts grew and formed iPSC clones.
The repeat expansion rate between fibroblasts and the very
early iPSCs (passage 0) is similar to expansion during later iPSC
propagation (Fig. 3E). Third, there is a true expansion and con-
traction during cell reprogramming. However, this possibility
needs more experimental support. For example, one could dif-
ferentiate iPSCs back to fibroblasts and check the repeat
lengths. These new fibroblasts will have less somatic instability
because the iPSCs come from one fibroblast cell. Then, repro-
gram the newly generated fibroblasts back into iPSCs and check
the length of the repeats. Although this process will not fully
answer the question, it can further confirm expansion and con-
traction during the reprogramming.
Is MSH6 involved in GAATTC triplet-repeat expansion?
Several studies have pointed to the involvement of MutS
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(MSH2/MSH3) in triplet-repeat instability in transgenic mice
(8, 15, 39). Our previous ChIP assays (16) also show that at a
resolution of1 kb, there is an increased occupancy of MSH2
and MSH3 downstream of the GAATTC triplet repeats in
FRDA iPSCs compared with an unaffected iPSC line, but, in
contrast, not 1254 bp upstream of the FXN transcriptional start
site or directly upstream of the GAATTC triplet repeats. In
addition, no differences inMSH6 occupancy were found at any
of the regions probed. However, these results cannot rule out
the involvement of MSH6 in GAATTC triplet-repeat expan-
sion. One possibility is that MSH6 may have an indirect effect
on GAATTC triplet-repeat expansion in iPSCs. Because the
mechanism of MMR in mammalian cells is not well under-
stood, future biochemical studies could investigate the function
of MSH6 in MMR. iPSCs clearly provide a mammalian cell
model to study the mechanisms of MMR.
Are other factors involved in GAATTC triplet-repeat
expansion? Higher expression of mismatch enzymes in iPSCs
could be one key factor that promotes the GAATTC triplet-
repeat expansion. However, two results suggest that there may
be other factors contributing to GAATTC triplet-repeat
expansion in iPSCs. First, asymptomatic heterozygous carriers
show GAATTC triplet-repeat expansion only on the patho-
genic allele, but not on the normal allele in FRDA iPSCs (16).
This result strongly supports models in which expanded alleles
adopt non-B DNA structures, which in turn promote further
expansion by recruitment of the MMR enzymes. However, the
exact mechanisms involved in MMR recruitment remain to be
FIGURE 6.Polyamide FA1,which targetsGAATTC triplet-repeatDNA, partially blocks repeat expansion in FRDA iPSCs.A, polyamide FA1 sequence and
binding model. B, polyamide HIV-1 sequence and binding model. Filled and open circles are imidazole (Im) and pyrrole (Py) rings, respectively; diamonds are
-alanine (); the curved line is -aminobutyric acid (); and the semicirclewith a plus sign is dimethylaminopropylamine (Dp). C and D, PCR of GAATTC triplet
repeats and GAATTC triplet-repeat expansion rate (over passage (P)), respectively, in untreated, FA1-treated and HIV-1-treated iPSCs. The HIV-1 polyamide
targetsCTGCAGtriplet-repeatDNA. E, polyamideFA1 targetingGAATTC triplet-repeatDNAdisplacesMSH2 from FXN intron1 inFRDA iPSCs. F,MSH2-targeted
shRNA (shMSH2) displacesMSH2 from FXN intron1 in FRDA iPSCs. ChIP experimentswereperformedwith anti-MSH2antibody in FRDA iPSCsusingPCRprimers
for a region on the FXN gene 1254 bp upstream of the transcriptional start site (1254) and upstream (up GAA) and downstream (down GAA) of the GAATTC
triplet-repeat expansion. Immunoprecipitation recovery is relative to intron 2.
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identified. Second, in FRDA patients, somatic GAATTC trip-
let-repeat instability is tissue-specific. This finding could impli-
cate other, as yet unidentified factors in repeat expansion.
Because we cannot target FXN transcription, DNA replication,
or active MMR enzymes to block GAATTC triplet-repeat
instability, factors that are specifically related to this instability
could represent a potential drug target to treat FRDA.
Specific -alanine-linked pyrrole-imidazole polyamides
could be one way to impede the GAATTC triplet-repeat
expansion. Although the existence ofGAATTCand other trip-
let-repeat sequences has been known for some time, there is
still no effective method or compound to prevent repeat insta-
bility in vivo. In this study, we have shown that a specific poly-
amide (FA1) can impede the GAATTC triplet-repeat expan-
sion in FRDA iPSCs, likely by binding and displacing MMR
enzymes from the repeats. This observation opens a new ave-
nue for investigating and designing new compounds that have
the ability to target GAATTC triplet repeats, as well as other
repeats, to block repeat instability. The ability to impede expan-
sion raises the hope that the severity of pathophysiology might
be reduced or its onset delayed, therebywidening the therapeu-
tic window for these deadly triplet-repeat diseases (3).
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